Characteristics and Risks of Endophthalmitis after 25-gauge Vitrectomy Surgery over a 14-year Period
Ophthalmology Retina · 2025-06 · 9 (6) · 556-563
DOI: 10.1016/j.oret.2024.11.019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ophthalmology Retina, 2025-06. Verfasst von Chase W Miller und 5 weiteren Autor:innen. Beteiligte Einrichtung: Creighton University School of Medicine, Omaha, Nebraska. Hauptthemen laut MEDLINE: Vitrectomy, Endophthalmitis, Visual Acuity, Postoperative Complications. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 14 Literaturangaben. Gefördert von: Astellas Pharma US.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Creighton University School of Medicine, Omaha, Nebraska.
- University of Toledo College of Medicine and Life Sciences, Toledo, Ohio.
- Retina Associates of Cleveland Inc., Cleveland, Ohio.
- Retina Associates of Cleveland Inc., Cleveland, Ohio. Electronic address: dmiller@retina-assoc.com.
Förderung
- Astellas Pharma US
Zitieren
APA
Miller, C. W., Rabljenovic, A., Papproth, C., Sciulli Md, H., Platt Md, S., & Miller, D. G. (2025). Characteristics and Risks of Endophthalmitis after 25-gauge Vitrectomy Surgery over a 14-year Period. Ophthalmology Retina, 9(6), 556-563. https://doi.org/10.1016/j.oret.2024.11.019
Vancouver
Miller CW, Rabljenovic A, Papproth C, Sciulli Md H, Platt Md S, Miller DG. Characteristics and Risks of Endophthalmitis after 25-gauge Vitrectomy Surgery over a 14-year Period. Ophthalmology Retina. 2025;9(6):556-563. doi:10.1016/j.oret.2024.11.019
BibTeX
@article{Miller2025,
author = {Miller, Chase W and Rabljenovic, Anja and Papproth, Cassie and Sciulli Md, Harrison and Platt Md, Sean and Miller, David G},
title = {Characteristics and Risks of Endophthalmitis after 25-gauge Vitrectomy Surgery over a 14-year Period},
journal = {Ophthalmology Retina},
year = {2025},
volume = {9},
number = {6},
pages = {556--563},
doi = {10.1016/j.oret.2024.11.019}
}
EUVIMED